Vitamin D Receptor Gene as a Candidate Gene for Parkinson Disease

Annals of Human Genetics

Volumn 75, Issue 2, 2011, Pages 201-210

  Butler, Megan W ^a   Burt, Amber ^b   Edwards, Todd L ^b,c   Zuchner, Stephan ^b   Scott, William K ^b   Martin, Eden R ^b   Vance, Jeffery M ^b   Wang, Liyong ^b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^c VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Age at onset; Genetic susceptibility; Parkinson disease; Vitamin D; Vitamin D receptor

Indexed keywords

VITAMIN D; VITAMIN D RECEPTOR;

ALZHEIMER DISEASE; ARTICLE; GENETIC ASSOCIATION; HUMAN; MAJOR CLINICAL STUDY; MULTIPLE SCLEROSIS; PARKINSON DISEASE; PRIORITY JOURNAL; QUANTITATIVE TRAIT; SINGLE NUCLEOTIDE POLYMORPHISM;

AGE OF ONSET; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; PARKINSON DISEASE; POLYMORPHISM, SINGLE NUCLEOTIDE; QUANTITATIVE TRAIT LOCI; RECEPTORS, CALCITRIOL; VITAMIN D;

EID: 79851478250     PISSN: 00034800     EISSN: 14691809     Source Type: Journal    
DOI: 10.1111/j.1469-1809.2010.00631.x     Document Type: Article

References (63)

1. Barrett, J. C., Fry, B., Maller, J. & Daly, M. J. (2005) Haploview: Analysis and visualization of LD and haplotype maps. Bioinformatics 21, 263-265.
2. Beecham, G. W., Martin, E. R., Li, Y. J., Slifer, M.A., Gilbert, J.R., Haines, J.L. & Pericak-Vance, M.A. (2009) Genome-wide association study implicates a chromosome 12 risk locus for late-onset alzheimer disease. Am J Hum Genet 84, 35-43.
3. Burne, T. H., McGrath, J. J., Eyles, D. W. & Mackay-Sim, A. (2005) Behavioural characterization of vitamin D receptor knockout mice. Behav Brain Res 157, 299-308.
4. Chan, C. S., Gertler, T. S. & Surmeier, D. J. (2009) Calcium homeostasis, selective vulnerability and Parkinson's disease. Trends Neurosci 32, 249-256.
5. Deluca, H. F. & Cantorna, M. T. (2001) Vitamin D: Its role and uses in immunology. FASEB J 15, 2579-2585.
6. Destefano, A. L., Lew, M. F., Golbe, L. I., Mark, M. H., Lazzarini, A. M., Guttman, M., Montgomery, E., Waters, C. H., Singer, C., Watts, R. L., Currie, L. J., Wooten, G. F., Maher, N. E., Wilk, J. B., Sullivan, K. M., Slater, K. M., Saint-Hilaire, M. H., Feldman, R. G., Suchowersky, O., Lafontaine, A. L., Labelle, N., Growdon, J. H., Vieregge, P., Pramstaller, P. P., Klein, C., Hubble, J. P., Reider, C. R., Stacy, M., MacDonald, M. E., Gusella, J. F. & Myers, R. H. (2002) PARK3 influences age at onset in Parkinson disease: A genome scan in the GenePD study. Am J Hum Genet 70, 1089-1095.
7. Destefano, A. L., Latourelle, J., Lew, M. F., Suchowersky, O., Klein, C., Golbe, L. I., Mark, M. H., Growdon, J. H., Wooten, G. F., Watts, R., Guttman, M., Racette, B. A., Perlmutter, J. S., Marlor, L., Shill, H. A., Singer, C., Goldwurm, S., Pezzoli, G., Saint-Hilaire, M. H., Hendricks, A. E., Gower, A., Williamson, S., Nagle, M. W., Wilk, J. B., Massood, T., Huskey, K. W., Baker, K. B., Itin, I., Litvan, I., Nicholson, G., Corbett, A., Nance, M., Drasby, E., Isaacson, S., Burn, D. J., Chinnery, P. F., Pramstaller, P. P., Al-Hinti, J., Moller, A. T., Ostergaard, K., Sherman, S. J., Roxburgh, R., Snow, B., Slevin, J. T., Cambi, F., Gusella, J. F. & Myers, R. H. (2008) Replication of association between ELAVL4 and Parkinson disease: The GenePD study. Hum Genet 124, 95-99.
8. Edwards, T. L., Lewis, K., Velez, D. R., Dudek, S. & Ritchie, M. D. (2009) Exploring the performance of multifactor dimensionality reduction in large scale SNP studies and in the presence of genetic heterogeneity among epistatic disease models. Hum Hered 67, 183-192.
9. Edwards, T. L., Scott, W. K., Almonte, C., Burt, A., Powell, E. H., Beecham, G. W., Wang, L., Zuchner, S., Konidari, I., Wang, G., Singer, C., Nahab, F., Scott, B., Stajich, J. M., Pericak-Vance, M., Haines, J., Vance, J. M. & Martin, E. R. (2010) Genome-wide association study confirms SNPs in SNCA and the MAPT region as common risk factors for Parkinson disease. Annals of Hum Genet 74, 97-109.
10. Evans, R. M. (1988) The steroid and thyroid hormone receptor superfamily. Science 240, 889-895.
11. Evatt, M. L., Delong, M. R., Khazai, N., Rosen, A., Triche, S. & Tangpricha, V. (2008) Prevalence of vitamin D insufficiency in patients with Parkinson disease and Alzheimer disease. Arch Neurol 65, 1348-1352.
12. Eyles, D. W., Smith, S., Kinobe, R., Hewison, M. & McGrath, J. J. (2005) Distribution of the vitamin D receptor and 1 alpha-hydroxylase in human brain. J Chem Neuroanat 29, 21-30.
13. Ferrari, G., Cusella-De Angelis, G., Coletta, M., Paolucci, E., Stornaiuolo, A., Cossu, G. & Mavilio, F. (1998) Muscle regeneration by bone marrow-derived myogenic progenitors. Science 279, 1528-1530.
14. Gao, X., Starmer, J. & Martin, E. R. (2008) A multiple testing correction method for genetic association studies using correlated single nucleotide polymorphisms. Genet Epidemiol 32, 361-369.
15. Garcion, E., Wion-Barbot, N., Montero-Menei, C. N., Berger, F. & Wion, D. (2002) New clues about vitamin D functions in the nervous system. Trends Endocrinol Metab 13, 100-105.
16. Gash, D. M., Zhang, Z., Ovadia, A., Cass, W. A., Yi, A., Simmerman, L., Russell, D., Martin, D., Lapchak, P. A., Collins, F., Hoffer, B. J. & Gerhardt, G. A. (1996) Functional recovery in parkinsonian monkeys treated with GDNF. Nature 380, 252-255.
17. Gezen-Ak, D., Dursun, E., Ertan, T., Hanagasi, H., Gurvit, H., Emre, M., Eker, E., Ozturk, M., Engin, F. & Yilmazer, S. (2007) Association between vitamin D receptor gene polymorphism and Alzheimer's disease. Tohoku J Exp Med 212, 275-282.
18. Gill, S. S., Patel, N. K., Hotton, G. R., O'Sullivan, K., McCarter, R., Bunnage, M., Brooks, D. J., Svendsen, C. N. & Heywood, P. (2003) Direct brain infusion of glial cell line-derived neurotrophic factor in Parkinson disease. Nat Med 9, 589-595.
19. Hancock, D. B., Martin, E. R., Fujiwara, K., Stacy, M. A., Scott, B. L., Stajich, J. M., Jewett, R., Li, Y. J., Hauser, M. A., Vance, J. M. & Scott, W. K. (2006) NOS2A and the modulating effect of cigarette smoking in Parkinson's disease. Ann Neurol 60, 366-373.
20. Hancock, D. B., Martin, E. R., Vance, J. M. & Scott, W. K. (2008) Nitric oxide synthase genes and their interactions with environmental factors in Parkinson's disease. Neurogenetics 9, 249-262.
21. Horne, B. D., Camp, N. J., Anderson, J. L., Mower, C. P., Clarke, J. L., Kolek, M. J., Carlquist, J. F. & Intermountain Heart Collaborative Study Group (2007) Multiple less common genetic variants explain the association of the cholesteryl ester transfer protein gene with coronary artery disease. J Am Coll Cardiol 49, 2053-2060.
22. Kim, J. S., Kim, Y. I., Song, C., Yoon, I., Park, J. W., Choi, Y. B., Kim, H. T. & Lee, K. S. (2005) Association of vitamin D receptor gene polymorphism and Parkinson's disease in Koreans. J Korean Med Sci 20, 495-498.
23. Knekt, P., Kilkkinen, A., Rissanen, H., Marniemi, J., Saaksjarvi, K. & Heliovaara, M. (2010) Serum vitamin D and the risk of Parkinson disease. Arch Neurol 67, 808-811.
24. Kordower, J. H., Emborg, M. E., Bloch, J., Ma, S. Y., Chu, Y., Leventhal, L., McBride, J., Chen, E. Y., Palfi, S., Roitberg, B. Z., Brown, W. D., Holden, J. E., Pyzalski, R., Taylor, M. D., Carvey, P., Ling, Z., Trono, D., Hantraye, P., Deglon, N. & Aebischer, P. (2000) Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease. Science 290, 767-773.
25. Latourelle, J. C., Pankratz, N., Dumitriu, A., Wilk, J. B., Goldwurm, S., Pezzoli, G., Mariani, C. B., DeStefano, A. L., Halter, C., Gusella, J. F., Nichols, W. C., Myers, R. H., Foroud, T., PROGENI Investigators, Coordinators and Molecular Genetic Laboratories & GenePD Investigators, Coordinators and Molecular Genetic Laboratories (2009) Genomewide association study for onset age in Parkinson disease. BMC medical genetics 10, 98.
26. Li, Y., Oliveira, S., Xu, P., Martin, E., Stenger, J., Hulette, C., Scherzer, C., Hauser, M., Scott, W., Small, G., Nance, M., Watts, R., Hubble, J., Koller, W., Pahwa, R., Stern, M., Hiner, B., Jancovic, J., Goetz, C., Mastaglia, F., Middleton, L., Roses, A., Saunders, A., Welsh-Bohmer, K., Schmechel, D., Gullans, S., Haines, J., Gilbert, J., Vance, J. & Pericak-Vance, M. (2003) Glutathione S-transferase modifies age-at-onset of Alzheimer disease and Parkinson disease. Hum Mol Genet 24, 3259-3267.
27. Li, Y., Oliveira, S. A., Xu, P., Martin, E. R., Stenger, J. E., Scherzer, C. A., Hulette, C., Scott, W. K., Small, G. W., Nance, M. A., Watts, R. L., Hubble, J. P., Koller, W. C., Pahwa, R., Stern, M. B., Hiner, B. C., Jankovic, J., Goetz, C. G., Mastaglia, F., Middleton, L. T., Roses, A. D., Saunders, A. M., Welsh-Bohmer, K. A., Schmechel, D. E., Gullans, S. R., Haines, J. L., Gilbert, J. R., Vance, J. M. & Pericak-Vance, M. A. (2003) Glutathione S-transferase omega-1 modifies age-at-onset of Alzheimer disease and Parkinson disease. Hum Mol Genet 12, 3259-3267.
28. Li, Y., Schrodi, S., Rowland, C., Tacey, K., Catanese, J. & Grupe, A. (2006) Genetic evidence for ubiquitin-specific proteases USP24 and USP40 as candidate genes for late-onset Parkinson disease. Hum Mutat 27, 1017-1023.
29. Li, Y., Scott, W. K., Hedges, D. J., Zhang, F., Gaskell, P. C., Nance, M. A., Watts, R. L., Hubble, J. P., Koller, W. C., Pahwa, R., Stern, M. B., Hiner, B. C., Jankovic, J., Allen, F. A., Jr., Goetz, C. G., Mastaglia, F., Stajich, J. M., Gibson, R. A., Middleton, L. T., Saunders, A. M., Scott, B. L., Small, G. W., Nicodemus, K. K., Reed, A. D., Schmechel, D. E., Welsh-Bohmer, K. A., Conneally, P. M., Roses, A. D., Gilbert, J. R., Vance, J. M., Haines, J. L. & Pericak-Vance, M. A. (2002) Age at onset in two common neurodegenerative diseases is genetically controlled. Am J Hum Genet 70, 985-993.
30. MA, N., Qin X-J., SA, O., TA, S., Van Der Walt J. M., MA, H., Pericak-Vance, M.A. & JM, V. (2005) Association between the neuron-specific RNA-binding protein ELAVL4 and Parkinson disease. Hum Genet 117, 27-33.
31. Maher, N. E., Golbe, L. I., Lazzarini, A. M., Mark, M. H., Currie, L. J., Wooten, G. F., Saint-Hilaire, M., Wilk, J. B., Volcjak, J., Maher, J. E., Feldman, R. G., Guttman, M., Lew, M., Schuman, S., Suchowersky, O., Lafontaine, A. L., Labelle, N., Vieregge, P., Pramstaller, P. P., Klein, C., Hubble, J., Reider, C., Growdon, J., Watts, R., Montgomery, E., Baker, K., Singer, C., Stacy, M. & Myers, R. H. (2002) Epidemiologic study of 203 sibling pairs with Parkinson's disease: The GenePD study. Neurology 58, 79-84.
32. Mamutse, G., Woolmore, J., Pye, E., Partridge, J., Boggild, M., Young, C., Fryer, A., Hoban, P. R., Rukin, N., Alldersea, J., Strange, R. C. & Hawkins, C. P. (2008) Vitamin D receptor gene polymorphism is associated with reduced disability in multiple sclerosis. Mult Scler 14, 1280-1283.
33. Maraganore, D. M., de Andrade, M., Elbaz, A., Farrer, M. J., Ioannidis, J. P., Kruger, R., Rocca, W. A., Schneider, N. K., Lesnick, T. G., Lincoln, S. J., Hulihan, M. M., Aasly, J. O., Ashizawa, T., Chartier-Harlin, M. C., Checkoway, H., Ferrarese, C., Hadjigeorgiou, G., Hattori, N., Kawakami, H., Lambert, J. C., Lynch, T., Mellick, G. D., Papapetropoulos, S., Parsian, A., Quattrone, A., Riess, O., Tan, E. K., Van Broeckhoven, C. & Genetic Epidemiology of Parkinson's Disease (GEO-PD) Consortium (2006) Collaborative analysis of alpha-synuclein gene promoter variability and Parkinson disease. JAMA 296, 661-670.
34. Marchini, J., Howie, B., Myers, S., McVean, G. & Donnelly, P. (2007) A new multipoint method for genome-wide association studies by imputation of genotypes. Nat Genet 39, 906-913.
35. Martin, E. R., Monks, S. A., Warren, L. L. & Kaplan, N. L. (2000) A test for linkage and association in general pedigrees: The pedigree disequilibrium test. Am J Hum Genet 67, 146-154.
36. McCulloch, C. C., Kay, D. M., Factor, S. A., Samii, A., Nutt, J. G., Higgins, D. S., Griffith, A., Roberts, J. W., Leis, B. C., Montimurro, J. S., Zabetian, C. P. & Payami, H. (2008) Exploring gene-environment interactions in Parkinson's disease. Hum Genet 123, 257-265.
37. McDonnell, S. K., Schaid, D. J., Elbaz, A., Strain, K. J., Bower, J. H., Ahlskog, J. E., Maraganore, D. M. & Rocca, W. A. (2006) Complex segregation analysis of Parkinson's disease: The Mayo Clinic Family Study. Ann Neurol 59, 788-795.
38. Mizuta, I., Satake, W., Nakabayashi, Y., Ito, C., Suzuki, S., Momose, Y., Nagai, Y., Oka, A., Inoko, H., Fukae, J., Saito, Y., Sawabe, M., Murayama, S., Yamamoto, M., Hattori, N., Murata, M. & Toda, T. (2006) Multiple candidate gene analysis identifies alpha-synuclein as a susceptibility gene for sporadic Parkinson's disease. Hum Molec Genet 15, 1151-1158.
39. Mizuta, I., Tsunoda, T., Satake, W., Nakabayashi, Y., Watanabe, M., Takeda, A., Hasegawa, K., Nakashima, K., Yamamoto, M., Hattori, N., Murata, M. & Toda, T. (2008) Calbindin 1, fibroblast growth factor 20, and alpha-synuclein in sporadic Parkinson's disease. Hum Genet 124, 89-94.
40. Monks, S. A. & Kaplan, N. L. (2000) Removing the sampling restrictions from family-based tests of association for a quantitative-trait locus. Am J Hum Genet 66, 576-592.
41. Moonesinghe, R., Khoury, M. J. & Janssens, A. C. (2007) Most published research findings are false-but a little replication goes a long way. PLoS med 4, e28.
42. Naveilhan, P., Neveu, I., Wion, D. & Brachet, P. (1996) 1, 25-Dihydroxyvitamin D3, an inducer of glial cell line-derived neurotrophic factor. Neuroreport 7, 2171-2175.
43. Niino, M., Fukazawa, T., Yabe, I., Kikuchi, S., Sasaki, H. & Tashiro, K. (2000) Vitamin D receptor gene polymorphism in multiple sclerosis and the association with HLA class II alleles. J Neurol Sci 177, 65-71.
44. Oliveira, S. A., Li, Y. J., Noureddine, M. A., Zuchner, S., Qin, X., Pericak-Vance, M. A. & Vance, J. M. (2005) Identification of risk and age-at-onset genes on chromosome 1p in Parkinson disease. Am J Hum Genet 77, 252-264.
45. Oliveira, S. A., Scott, W. K., Nance, M. A., Watts, R. L., Hubble, J. P., Koller, W. C., Lyons, K. E., Pahwa, R., Stern, M. B., Hiner, B. C., Jankovic, J., Ondo, W. G., Allen, F. H., Jr., Scott, B. L., Goetz, C. G., Small, G. W., Mastaglia, F. L., Stajich, J. M., Zhang, F., Booze, M. W., Reaves, J. A., Middleton, L. T., Haines, J. L., Pericak-Vance, M. A., Vance, J. M. & Martin, E. R. (2003) Association study of Parkin gene polymorphisms with idiopathic Parkinson disease. Arch Neurol 60, 975-980.
46. Partridge, J. M., Weatherby, S. J., Woolmore, J. A., Highland, D. J., Fryer, A. A., Mann, C. L., Boggild, M. D., Ollier, W. E., Strange, R. C. & Hawkins, C. P. (2004) Susceptibility and outcome in MS: Associations with polymorphisms in pigmentation-related genes. Neurology 62, 2323-2325.
47. Ponsonby, A. L., Pezic, A., Ellis, J., Morley, R., Cameron, F., Carlin, J. & Dwyer, T. (2008) Variation in associations between allelic variants of the vitamin D receptor gene and onset of type 1 diabetes mellitus by ambient winter ultraviolet radiation levels: A meta-regression analysis. Am J Epidemiol 168, 358-365.
48. Purcell, S., Neale, B., Todd-Brown, K., Thomas, L., Ferreira, M. A., Bender, D., Maller, J., Sklar, P., de Bakker, P. I., Daly, M. J. & Sham, P. C. (2007) PLINK: A tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 81, 559-575.
49. Sato, Y., Honda, Y., Iwamoto, J., Kanoko, T. & Satoh, K. (2005) Abnormal bone and calcium metabolism in immobilized Parkinson's disease patients. Mov Disord 20, 1598-1603.
50. Sato, Y., Kikuyama, M. & Oizumi, K. (1997) High prevalence of vitamin D deficiency and reduced bone mass in Parkinson's disease. Neurology 49, 1273-1278.
51. Scherzer, C. R., Eklund, A. C., Morse, L. J., Liao, Z., Locascio, J. J., Fefer, D., Schwarzschild, M. A., Schlossmacher, M. G., Hauser, M. A., Vance, J. M., Sudarsky, L. R., Standaert, D. G., Growdon, J. H., Jensen, R. V. & Gullans, S. R. (2007) Molecular markers of early Parkinson's disease based on gene expression in blood. Proc Natl Acad Sci U S A 104, 955-960.
52. Schrauwen, I., Ealy, M., Huentelman, M. J., Thys, M., Homer, N., Vanderstraeten, K., Fransen, E., Corneveaux, J. J., Craig, D. W., Claustres, M., Cremers, C. W., Dhooge, I., Van de Heyning, P., Vincent, R., Offeciers, E., Smith, R. J. & Van Camp, G. (2009) A genome-wide analysis identifies genetic variants in the RELN gene associated with otosclerosis. Am J Hum Genet 84, 328-338.
53. Smith, M. P., Fletcher-Turner, A., Yurek, D. M. & Cass, W. A. (2006) Calcitriol protection against dopamine loss induced by intracerebroventricular administration of 6-hydroxydopamine. Neurochem Res 31, 533-539.
54. Smolders, J., Peelen, E., Thewissen, M., Menheere, P., Cohen Tervaert, J. W., Hupperts, R. & Damoiseaux, J. (2009) The relevance of vitamin D receptor gene polymorphisms for vitamin D research in multiple sclerosis. Autoimmun Rev 8, 621-626.
55. Tajouri, L., Ovcaric, M., Curtain, R., Johnson, M. P., Griffiths, L. R., Csurhes, P., Pender, M. P. & Lea, R. A. (2005) Variation in the vitamin D receptor gene is associated with multiple sclerosis in an Australian population. J Neurogenet 19, 25-38.
56. Thomas, B. & Beal, M. F. (2007) Parkinson's disease. Hum Molec Genet 16, R183-R194.
57. Uitterlinden, A. G., Fang, Y., Van Meurs, J. B., Pols, H. A. & Van Leeuwen, J. P. (2004) Genetics and biology of vitamin D receptor polymorphisms. Gene 338, 143-156.
58. Van Der Walt, J. M., Noureddine, M. A., Kittappa, R., Hauser, M. A., Scott, W. K., McKay, R., Zhang, F., Stajich, J. M., Fujiwara, K., Scott, B. L., Pericak-Vance, M. A., Vance, J. M. & Martin, E. R. (2004) Fibroblast growth factor 20 polymorphisms and haplotypes strongly influence risk of Parkinson disease. Am J Hum Genet 74, 1121-1127.
59. Wahner, A. D., Sinsheimer, J. S., Bronstein, J. M. & Ritz, B. (2007) Inflammatory cytokine gene polymorphisms and increased risk of Parkinson disease. Arch Neurol 64, 836-840.
60. Wang, L., Hauser, E. R., Shah, S. H., Seo, D., Sivashanmugam, P., Exum, S. T., Gregory, S. G., Granger, C. B., Haines, J. L., Jones, C. J., Crossman, D., Haynes, C., Kraus, W. E., Freedman, N. J., Pericak-Vance, M. A., Goldschmidt-Clermont, P. J. & Vance, J. M. (2008a) Polymorphisms of the tumor suppressor gene LSAMP are associated with left main coronary artery disease. Ann Hum Genet 72, 443-453.
61. Wang, G., Van Der Walt, J. M., Mayhew, G. M., Li, Y., Zuchner, S., Scott, W. K., Martin, E. R. & Vance, J. M. (2008b) Variation in the miRNA-433 binding site of FGF20 confers risk for Parkinson disease by over-expression of α-synuclein. Am J Hum Genet 82, 283-289.
62. Wang, J. Y., Wu, J. N., Cherng, T. L., Hoffer, B. J., Chen, H. H., Borlongan, C. V. & Wang, Y. (2001) Vitamin D(3) attenuates 6-hydroxydopamine-induced neurotoxicity in rats. Brain research 904, 67-75.
63. Winkler, S., Hagenah, J., Lincoln, S., Heckman, M., Haugarvoll, K., Lohmann-Hedrich, K., Kostic, V., Farrer, M. & Klein, C. (2007) alpha-Synuclein and Parkinson disease susceptibility. Neurology 69, 1745-1750.